Should you buy, sell or hold IndusInd Bank, Maruti Suzuki, Zomato, HDFC Life shares?

Which stocks to buy, hold or sell today? As Dalal Street enters the April 25 session, here's a look at what brokerages make of some of the key stocks that are trending today. Stocks such as IndusInd Bank, Maruti Suzuki, Zomato, HDFC Life Insurance, Apollo Hospitals, Macrotech Developers, and other shares are on their radar today.

Here is a list of brokerage calls on some of the stocks in focus today, including IndusInd Bank, Maruti Suzuki. | Image Source: Pixabay

Which stocks to buy, hold or sell today? As Dalal Street enters the April 25 session, here's a look at what brokerages make of some of the key stocks that are in focus.

Stocks such as IndusInd Bank, Maruti Suzuki, Zomato, HDFC Life Insurance, Apollo Hospitals, Macrotech Developers, and other shares are on their radar today.

Do you have any of these stocks in your portfolio?

TRENDING NOW

Check out the full list of what brokerages recommend, including IndusInd Bank, Maruti Suzuki, Zomato, HDFC Life Insurance, Apollo Hospitals, Macrotech Developers, and other stocks:

IndusInd Bank

Global brokerages are upbeat on IndusInd Bank shares a day after the private lender announced its March quarter earnings. The bank reported a 46 per cent jump in its March quarter net profit at Rs 2,043 crore on a dip in provisions and stronger core income.

Brokerage	Rating	Price Target
CLSA	Buy	Rs 1,500
Morgan Stanley	Overweight	Rs 1,525
JP Morgan	Neutral	Rs 1,060
Jefferies	Buy	Rs 1,550
Goldman Sachs	Buy	Raised to Rs 1,522 from Rs 1,411
Citi	Buy	Cut to Rs 1,380 from Rs Rs 1,411
Macquarie	Outperform	Rs 1,510

Maruti Suzuki

Most brokerages are bullish on Maruti Suzuki India ahead of its fourth-quarter earnings on Wednesday. Citi maintained a ‘buy’ rating, while Macquarie has an ‘outperform’ stance and Nomura gives a 'neutral' call on the stock.

Brokerage	Rating	Price Target
Citi	Buy	Rs 12,500
Macquarie	Outperform	Rs 10,508
Nomura	Neutral	Rs 9928

Zomato

Citi retains a ‘buy’ call, while Morgan Stanley has an ‘overweight’ call on Zomato – an online food delivery company.

Brokerage	Rating	Price Target
Citi	Buy	Rs 76
Morgan Stanley	Overweight	Cut to Rs 74 from Rs Rs 82

Citi in its commentary said, “Both Zomato and Swiggy have introduced monetisation in the dining out the segment. While this appears to be a limited roll-out for now, nevertheless, it is positive for medium-term platform monetization.”

HDFC Life Insurance

Brokerage	Rating	Price Target
Citi	Buy	Rs 595
Morgan Stanley	Overweight	Rs 650

Apollo Hospitals

Brokerage	Rating	Price Target
Goldman Sachs	Buy	Cut to Rs 5,050 from Rs Rs 5,100
Nomura	Buy	Rs 5,107

Macrotech Developers

Brokerage	Rating	Price Target
CLSA	Outperform	Cut to Rs 1,048 from Rs 1,083
JP Morgan	Neutral	Cut to Rs 1,050 from Rs 1,100

Catch the latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.

(Disclaimer: The views/suggestions/advices expressed here in this article is solely by investment experts. Zee Business suggests its readers to consult with their investment advisers before making any financial decision.)

TAGS: